Terrance P. Coyne insider trades: Royalty Pharma (RPRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Terrance reports to the SEC
Open-market buys and sales
35 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | RPRX | ↓ Sell | 11,002 | $58.68 | $646K | Tpc Rp Epa1 LLC | Aug 17, 2026 (4d) |
| May 26, 2026 | RPRX | ↓ Sell | 64,399 | $53.98 | $3.5M | Tpc Rp Epa1 LLC | May 28, 2026 (2d) |
| Apr 28, 2026 | RPRX | ↓ Sell | 32,916 | $49.78 | $1.6M | By TPC RP 2021, LLC | Apr 30, 2026 (2d) |
| Apr 28, 2026 | RPRX | ↓ Sell | 1,875 | $49.78 | $93K | Tpc Rp Epa1 LLC | Apr 30, 2026 (2d) |
| Apr 1, 2026 | RPRX | ↓ Sell | 32,916 | $48.33 | $1.6M | By TPC RP 2021, LLC | Apr 2, 2026 (1d) |
| Apr 1, 2026 | RPRX | ↓ Sell | 1,875 | $48.33 | $91K | Tpc Rp Epa1 LLC | Apr 2, 2026 (1d) |
| Mar 23, 2026 | RPRX | ↓ Sell | 32,916 | $45.53 | $1.5M | By TPC RP 2021, LLC | Mar 25, 2026 (2d) |
| Mar 23, 2026 | RPRX | ↓ Sell | 1,875 | $45.53 | $85K | Tpc Rp Epa1 LLC | Mar 25, 2026 (2d) |
| Mar 2, 2026 | RPRX | ↓ Sell | 32,916 | $46.78 | $1.5M | By TPC RP 2021, LLC | Mar 4, 2026 (2d) |
| Mar 2, 2026 | RPRX | ↓ Sell | 1,875 | $46.78 | $88K | Tpc Rp Epa1 LLC | Mar 4, 2026 (2d) |
| Feb 23, 2026 | RPRX | ↓ Sell | 32,916 | $45.32 | $1.5M | By TPC RP 2021, LLC | Feb 25, 2026 (2d) |
| Feb 23, 2026 | RPRX | ↓ Sell | 1,875 | $45.32 | $85K | Tpc Rp Epa1 LLC | Feb 25, 2026 (2d) |
| Feb 4, 2026 | RPRX | ↓ Sell | 230,416 | $42.54 | $9.8M | By TPC RP 2021, LLC | Feb 4, 2026 (0d) |
| Feb 4, 2026 | RPRX | ↓ Sell | 13,125 | $42.54 | $558K | Tpc Rp Epa1 LLC | Feb 4, 2026 (0d) |
| Jan 20, 2026 | RPRX | ↓ Sell | 65,832 | $39.35 | $2.6M | By TPC RP 2021, LLC | Jan 23, 2026 (3d) |
| Jan 20, 2026 | RPRX | ↓ Sell | 3,750 | $39.35 | $148K | Tpc Rp Epa1 LLC | Jan 23, 2026 (3d) |
| Jan 2, 2026 | RPRX | ↓ Sell | 65,832 | $38.42 | $2.5M | By TPC RP 2021, LLC | Jan 6, 2026 (4d) |
| Jan 2, 2026 | RPRX | ↓ Sell | 3,750 | $38.42 | $144K | Tpc Rp Epa1 LLC | Jan 6, 2026 (4d) |
| Dec 15, 2025 | RPRX | ↓ Sell | 65,832 | $38.36 | $2.5M | By TPC RP 2021, LLC | Dec 17, 2025 (2d) |
| Dec 15, 2025 | RPRX | ↓ Sell | 3,750 | $38.36 | $144K | Tpc Rp Epa1 LLC | Dec 17, 2025 (2d) |
| Dec 1, 2025 | RPRX | ↓ Sell | 65,832 | $39.87 | $2.6M | By TPC RP 2021, LLC | Dec 3, 2025 (2d) |
| Dec 1, 2025 | RPRX | ↓ Sell | 3,750 | $39.87 | $149K | Tpc Rp Epa1 LLC | Dec 3, 2025 (2d) |
| Nov 24, 2025 | RPRX | ↓ Sell | 65,832 | $38.55 | $2.5M | By TPC RP 2021, LLC | Nov 26, 2025 (2d) |
| Nov 24, 2025 | RPRX | ↓ Sell | 3,750 | $38.55 | $145K | Tpc Rp Epa1 LLC | Nov 26, 2025 (2d) |
| Nov 17, 2025 | RPRX | ↓ Sell | 65,844 | $39.30 | $2.6M | By TPC RP 2021, LLC | Nov 19, 2025 (2d) |
| Nov 17, 2025 | RPRX | ↓ Sell | 3,750 | $39.30 | $147K | Tpc Rp Epa1 LLC | Nov 19, 2025 (2d) |
| Aug 10, 2023 | RPRX | ↓ Sell | 75,000 | $30.73 | $2.3M | By TPC RP 2021, LLC | Aug 11, 2023 (1d) |
| Jul 13, 2023 | RPRX | ↓ Sell | 75,000 | $31.00 | $2.3M | By TPC RP 2021, LLC | Jul 14, 2023 (1d) |
| Nov 8, 2022 | RPRX | ↓ Sell | 24,500 | $43.47 | $1.1M | By TPC RP 2021, LLC | Nov 10, 2022 (2d) |
| Nov 2, 2022 | RPRX | ↓ Sell | 5,500 | $43.06 | $237K | By TPC RP 2021, LLC | Nov 4, 2022 (2d) |
| Aug 1, 2022 | RPRX | ↓ Sell | 30,000 | $43.19 | $1.3M | By TPC RP 2021, LLC | Aug 3, 2022 (2d) |
| Mar 3, 2021 | RPRX | ↓ Sell | 100,000 | $44.78 | $4.5M | By TPC RP, LLC | Mar 5, 2021 (2d) |
| Mar 2, 2021 | RPRX | ↓ Sell | 100,000 | $46.94 | $4.7M | By TPC RP, LLC | Mar 4, 2021 (2d) |
| Jun 18, 2020 | RPRX | ↑ Buy | 1,500 | $28.00 | $42K | Direct | Jun 23, 2020 (5d) |
| Jun 18, 2020 | RPRX | ↑ Buy | 1,450 | $28.00 | $41K | By Spouse | Jun 23, 2020 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RPRX insiders
Open-market trades in the last 12 months
About Terrance P. Coyne's insider trades
Terrance P. Coyne is EVP & CFO at Royalty Pharma (RPRX). Since Jun 18, 2020, Terrance has reported 2 open-market purchases worth $83K and 33 sales worth $55.4M on SEC Form 4. In the last 12 months: 26 sales ($39.0M).
Their filings also include grants and awards (8 filings), conversions (4 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RPRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.